
Christopher J. McGurk
About Christopher J. McGurk
Christopher J. McGurk, 68, is Chief Executive Officer and Chairman of the Board of Cineverse (CNVS) and has served in these roles since January 2011; prior senior leadership includes President/COO of Universal Pictures, Vice Chairman/COO of MGM (lead operating executive), and CFO/President of The Walt Disney Motion Picture Group, with MGM sold for approximately $5 billion during his tenure; education is not disclosed in the proxy . Company performance under his oversight improved in FY2025: revenues rose to $78.2M from $49.1M and net income turned positive to $3.8M (from a loss of $21.3M in FY2024), with Adjusted EBITDA improving to $13.9M (from $4.4M); CNVS’s pay-versus-performance TSR values were 25.15 (FY2023), 4.16 (FY2024), and 19.51 (FY2025) .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Metro-Goldwyn-Mayer (MGM) | Vice Chairman of the Board & COO | 1999–2005 | Lead operating executive until MGM sold for ~$5B to a consortium |
| Universal Pictures | President & COO | 1996–1999 | Senior operating roles across studio functions |
| The Walt Disney Studios | Studios CFO; President, Motion Picture Group | 1988–1996 | Finance and film group leadership |
| Overture Films | Founder & CEO | 2006–2010 | Built studio; later led Anchor Bay Entertainment distribution |
| Anchor Bay Entertainment | CEO | 2006–2010 | Drove home entertainment distribution for Overture’s products |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| IDW Media Holdings, Inc. | Director | Not disclosed | Prior public company board service |
| BRE Properties, Inc. | Director | Not disclosed | Prior public company board service |
| DivX Inc. | Director | Not disclosed | Prior public company board service |
| DIC Entertainment | Director | Not disclosed | Prior public company board service |
| Pricegrabber.com, LLC | Director | Not disclosed | Prior board service |
| MGM Studios, Inc. | Director | Not disclosed | Prior board service |
Fixed Compensation
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Base Salary ($) | 650,000 | 650,000 | 650,000 |
| All Other Compensation ($) | 39,431 | 39,286 | 39,912 |
| Total Compensation ($) | 2,623,650 | 1,014,286 | 939,182 |
Notes:
- Base salary set at $650,000 under both the 2022 and 2025 employment agreements .
- “All Other Compensation” includes life and disability insurance premiums and certain medical expenses .
Performance Compensation
| Incentive Type | Metric | Target | Actual | Payout | Vesting |
|---|---|---|---|---|---|
| MAIP Annual Bonus (FY2023) | Company financial plan and key performance metrics | Not disclosed | Achievement level not disclosed | $707,969 | Paid subsequent year; FY2023 bonuses paid in FY2024 |
| MAIP Annual Bonus (FY2024) | Company financial plan and key performance metrics | Not disclosed | Achievement level not disclosed | $325,000 | Paid subsequent year; FY2024 bonuses paid in FY2025 |
| MAIP Annual Bonus (FY2025) | Company financial plan and key performance metrics | Target bonus $650,000 per agreement | Not disclosed; proxy shows no bonus paid | $0 (—) | N/A |
| RSAs/RSUs (FY2025 grant) | Service-vesting; equity value tied to share price | N/A | N/A | Market value $948,000 as of 3/31/25 | 300,000 shares/units vest 1/3 on Apr 25, 2025/2026/2027 |
| 2025 Employment Agreement RSUs | Service-vesting | 120,000 RSUs | N/A | N/A | Vest in three equal annual installments; accelerated vesting on qualifying CIC termination |
| PSUs (2022 Agreement) | EBITDA and financial performance | Up to 25,000 shares | Not disclosed | Not disclosed | At least one-year performance; terms set by Compensation Committee |
| SARs (Grant 10/17/2022) | Equity value; service-vesting | 125,000 @ $9.60 | N/A | N/A | 1/3 vest on Apr 1 of 2023/2024/2025; 10-year term |
Additional long-term incentive disclosures:
- In FY2025, Company granted 150,000 restricted stock awards and 150,000 restricted stock units to the PEO, vesting 1/3 on Apr 25, 2025/2026/2027 .
- MAIP design: awards may be paid in cash or stock; targets based on approved financial plan and key performance metrics; FY2023 bonus paid in FY2024 and FY2024 bonus paid in FY2025 .
Equity Ownership & Alignment
| Item | Detail |
|---|---|
| Total Beneficial Ownership | 881,045 shares; 4.5% of Class A shares outstanding (19,124,406 shares) |
| Components | Includes 285,000 shares underlying currently exercisable SARs and 103,526 shares held by the Christopher and Jamie McGurk Living Trust (Mr. McGurk is a trustee) |
| Outstanding Awards (as of 3/31/2025) | RSAs/RSUs: 300,000 unvested; market value $948,000; vest 1/3 on Apr 25 of 2025/2026/2027 |
| Options/SARs (Exercisable) | 35,000 @ $29.40 exp 6/7/2028; 125,000 @ $10.80 exp 11/19/2030; 83,333 @ $9.60 exp 10/17/2032 |
| Options/SARs (Unexercisable) | 41,667 @ $9.60 exp 10/17/2032 |
| Hedging/Pledging | Company discourages hedging (e.g., collars, swaps) and restricts short sales; all insider trades require pre-clearance; pledging not specifically disclosed |
| Stock Ownership Guidelines | Non-employee directors must hold ≥3x annual cash retainer within 3 years; Brown, O’Brien, Halford meet guidelines as of 3/31/2025; executive ownership guidelines not disclosed |
Vesting schedule implications:
- Upcoming tranches: Apr 25, 2026 and Apr 25, 2027 for the remaining 200,000 RSAs/RSUs (100,000 per year), creating potential sale windows and technical overhang around vest dates .
Employment Terms
| Term | 2022 Employment Agreement | 2025 Employment Agreement |
|---|---|---|
| Agreement Date | Oct 17, 2022 | May 1, 2025 |
| Effective Date | Apr 1, 2023 | May 1, 2025 |
| Term End | Mar 31, 2026 | Apr 30, 2027 |
| Auto-Renewal | 1-year automatic renewal unless 90-day notice | 1-year automatic renewal unless 90-day notice |
| Role | CEO & Chairman | CEO & Chairman |
| Base Salary | $650,000 | $650,000 |
| Target Bonus | $650,000 (MAIP) | $650,000 (MAIP) |
| Equity | PSUs up to 25,000 shares (EBITDA targets); 125,000 SARs @ $9.60 (10-year term; 1/3 vest Apr 1 2023–2025) | RSUs for 120,000 shares; vest in three equal annual installments |
| Severance (No Cause/Good Reason) | Greater of salary for remainder of term or 18 months’ salary; plus 1.5x average of last two MAIP bonuses | Same: greater of remainder or 18 months’ salary; plus 1.5x average of last two MAIP bonuses |
| Change-in-Control (CIC) | Within 2 years post-CIC: unvested SARs immediately vest if termination without Cause; CIC severance alternative: 3x (salary + target bonus) | Within 2 years post-CIC: RSUs immediately vest if termination other than for Cause or resignation for Good Reason; CIC severance: lump sum 3x (salary + target bonus) |
| Clawback | Company Clawback Policy compliant with Dodd-Frank/Nasdaq; no recaptures to date | |
| Benefits | Participation in executive benefit plans |
Board Governance
- Board size: 4 directors; McGurk serves as Chairman & CEO; a Lead Independent Director (Patrick W. O’Brien) provides counterbalance, presiding over executive sessions and serving as liaison with independent directors and shareholders .
- Independence: Peter C. Brown, Patrick W. O’Brien, and Mary Ann Halford are independent under SEC/Nasdaq rules; board met 7 times in FY2025, with ≥75% attendance for all members .
- Committee memberships and leadership:
- Audit: Chair Peter C. Brown; members O’Brien, Halford .
- Compensation: Chair Mary Ann Halford; members Brown, O’Brien; Aon engaged as independent compensation consultant; no interlocks; one meeting in FY2025 .
- Nominating: Chair Patrick W. O’Brien; members Brown, Halford .
- Dual-role implications: Combined CEO/Chair can concentrate authority; mitigating structure includes a Lead Independent Director with defined responsibilities and regular executive sessions of independent directors .
Director compensation context (non-employee):
- Annual cash retainer $60,000; committee chair $15,000; committee member $5,000; Lead Independent Director supplemental $20,000; equity grants: $90,000 annual restricted stock (quarterly vesting) and $180,000 initial restricted stock for new directors (3-year vesting) .
Performance Snapshot
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenues ($000s) | — | 49,131 | 78,181 |
| Operating Income (Loss) ($000s) | — | (15,700) | 7,924 |
| Net Income (Loss) ($000s) | (9,694) (Company measure) | (21,265) | 3,764 |
| Adjusted EBITDA ($000s) | — | 4,398 | 13,917 |
| TSR value of $100 investment | 25.15 | 4.16 | 19.51 |
Notes:
- Revenue growth in FY2025 was driven by Terrifier 3 theatrical release (base distribution +$23.4M) and streaming/digital licensing (Dog Whisperer and Terrifier 3) .
Compensation Structure Analysis
- Equity mix increased in FY2025 via RSAs/RSUs (PEO 150,000 RSAs + 150,000 RSUs vesting over 3 years), shifting emphasis to long-term incentives tied to share performance; earlier years relied on SARs (e.g., 125,000 SARs granted in 2022), with significant option award value in FY2023 .
- MAIP bonuses were paid despite variable performance outcomes (FY2023: $707,969; FY2024: $325,000), with FY2025 showing no bonus payout for the PEO; MAIP is linked to the approved financial plan and key metrics, but specific weights/targets are not disclosed .
- CIC protections are substantial (3x salary + target bonus) and include accelerated vesting of unvested equity upon qualifying termination within 2 years post-CIC, which supports retention but may draw scrutiny on parachute magnitude .
Related Party Transactions and Compliance
- No significant reportable related party transactions since the beginning of FY2025; Audit Committee reviews related party matters per charter .
- Section 16(a) compliance: company believes no directors/executives or >10% holders failed to comply during FY2025 .
- Insider Trading Policy restricts trading on MNPI, short sales, and discourages hedging; pre-clearance required for all equity transactions .
Investment Implications
- Alignment and retention: Large scheduled RSAs/RSUs vesting on Apr 25, 2026/2027 and substantial CIC severance/accelerated vesting create strong retention levers; however, upcoming vest dates may introduce technical selling pressure and overhang risk as tranches vest .
- Pay-for-performance: FY2025 shows improved fundamentals (revenues, operating income, Adjusted EBITDA, net income) and better TSR vs FY2024; MAIP payouts are variable and equity awards tie outcomes to share performance, but disclosure on specific performance targets/weights is limited, reducing transparency for pay alignment assessment .
- Governance: Combined CEO/Chair role is mitigated by a strong Lead Independent Director, independent committee leadership, and regular executive sessions; committee structures and use of an independent consultant (Aon) support compensation governance quality .
- Risk flags: CIC multiple (3x) and accelerated vesting terms may be shareholder-sensitive; hedging discouraged and no pledging disclosures noted; no significant related party transactions or Section 16(a) issues reported .